These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11151795)

  • 1. Heart allograft endothelial cell dysfunction. Cause, course, and consequences.
    Weis M; Pehlivanli S; von Scheidt W
    Z Kardiol; 2000; 89 Suppl 9():IX/58-62. PubMed ID: 11151795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway.
    Weis M; Cooke JP
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):567-75. PubMed ID: 12649081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of quinaprilat on coronary vasomotor function, endothelial oxidative stress, and endothelin activation after human heart transplantation.
    Steinhauff S; Pehlivanli S; Bakovic-Alt R; Meiser BM; Becker BF; von Scheidt W; Weis M
    Transplantation; 2004 Jun; 77(12):1859-65. PubMed ID: 15223904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of morbidity and mortality from cardiac allograft vasculopathy.
    Deng MC; Baba HA; Plenz G; Erren M; Wilhelm MJ; Moennig G; Scheld HH
    Z Kardiol; 2000; 89 Suppl 9():IX/63-5. PubMed ID: 11151797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
    Koglin J
    Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of ACE inhibition on coronary endothelial dysfunction.
    Nickenig G; Stäblein A; Wassmann S; Wyen C; Müller C; Böhm M
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):361-4. PubMed ID: 11967824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation.
    Fedak PW; Rao V; Verma S; Ramzy D; Tumiati L; Miriuka S; Boylen P; Weisel RD; Feindel CM
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):407-15. PubMed ID: 15678053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation.
    Weis M; Pehlivanli S; Meiser BM; von Scheidt W
    J Am Coll Cardiol; 2001 Sep; 38(3):814-8. PubMed ID: 11527639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting the NO pathway with intracoronary L-NAME infusion increases endothelial dysfunction and intimal hyperplasia after heart transplantation.
    Perrault LP; Malo O; Bidouard JP; Villeneuve N; Vilaine JP; Vanhoutte PM
    J Heart Lung Transplant; 2003 Apr; 22(4):439-51. PubMed ID: 12681422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction and cardiac allograft vasculopathy.
    Colvin-Adams M; Harcourt N; Duprez D
    J Cardiovasc Transl Res; 2013 Apr; 6(2):263-77. PubMed ID: 23135991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injury of the coronary endothelium at implantation increases endothelial dysfunction and intimal hyperplasia after heart transplantation.
    El-Hamamsy I; Stevens LM; Vanhoutte PM; Perrault LP
    J Heart Lung Transplant; 2005 Mar; 24(3):251-8. PubMed ID: 15737750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant epicardial and microvascular endothelial responses in heart transplant recipients early after transplantation.
    Hollenberg SM; Tamburro P; Klein LW; Burns D; Easington C; Costanzo MR; Parrillo JE; Johnson MR
    J Heart Lung Transplant; 1998 May; 17(5):487-94. PubMed ID: 9628567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin in coronary endothelial dysfunction early after human heart transplantation.
    Weis M; Wildhirt SM; Schulze C; Rieder G; Wilbert-Lampen U; Wolf WP; Arendt RM; Enders G; Meiser BM; von Scheidt W
    J Heart Lung Transplant; 1999 Nov; 18(11):1071-9. PubMed ID: 10598730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Schlaifer JD; Wargovich TJ; O'Neill B; Mancini GB; Haber HE; Pitt B; Pepine CJ
    Am J Cardiol; 1997 Dec; 80(12):1594-7. PubMed ID: 9416943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic options for improvement of myocardial perfusion in coronary atherosclerosis].
    Schächinger V
    Herz; 1998 Mar; 23(2):116-29. PubMed ID: 9592707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coronary atherosclerosis and vascular endothelial dysfunction].
    Nishinaga M
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():75-9. PubMed ID: 12734956
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Schlaifer JD; Mancini GB; O'Neill BJ; Pitt B; Haber HE; Pepine CJ
    Cardiovasc Drugs Ther; 1999 May; 13(3):201-9. PubMed ID: 10439882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant.
    Davis SF; Yeung AC; Meredith IT; Charbonneau F; Ganz P; Selwyn AP; Anderson TJ
    Circulation; 1996 Feb; 93(3):457-62. PubMed ID: 8565162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.